Evidence map›Paper›PMID 34517413›Full record

ArticleBlood2022

Murine AGM single-cell profiling identifies a continuum of hemogenic endothelium differentiation marked by ACE.

Muhammad Zaki Hidayatullah Fadlullah, Wen Hao Neo, Michael Lie-A-Ling, Roshana Thambyrajah, Rahima Patel, Renaud Mevel, Irène Aksoy, Nam Do Khoa, Pierre Savatier, Laura Fontenille and 4 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Blood, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07607392 (JAK2V617F Mutated Endothelium Has a Stem Cell Potential in Primary Myelofibrosis), which is not on this map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
5.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07607392 completednot on this mapstarted 2023, after this paper: background citation

JAK2V617F Mutated Endothelium Has a Stem Cell Potential in Primary Myelofibrosis: a New Disease Ontogenesis for Chronic Myeloproliferative Disorders

TypeobservationalSponsorFondazione IRCCS Policlinico San Matteo di PaviaRan2023 to 2026Enrolled30ConditionsPrimary Myelofibrosids
3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Transition of signal requirement in hematopoietic stem cell development from hemogenic endothelial cells.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 3 countries.

Muhammad Zaki Hidayatullah FadlullahStem Cell Biology Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, United Kingdom.
Wen Hao NeoStem Cell Biology Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, United Kingdom.ORCID 0000-0002-6827-3027
Michael Lie-A-LingStem Cell Biology Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, United Kingdom.ORCID 0000-0003-0194-4313
Roshana ThambyrajahProgram in Cancer Research, Institut Hospital del Mar d'Investigacions Mèdiques, Centro de Investigación Biomédica en Red de Oncología (CIBERONC), Barcelona, Spain.ORCID 0000-0002-3941-760X
Rahima PatelStem Cell Biology Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, United Kingdom.
Renaud MevelStem Cell Biology Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, United Kingdom.ORCID 0000-0002-2742-6576
Irène AksoyUniversité Lyon 1, INSERM, Stem Cell and Brain Research Institute U1208, Bron, France.ORCID 0000-0003-4353-5876
Nam Do KhoaAzelead, Montpellier, France; and.
Pierre SavatierUniversité Lyon 1, INSERM, Stem Cell and Brain Research Institute U1208, Bron, France.
Laura FontenilleAzelead, Montpellier, France; and.
Syed Murtuza BakerDivision of Informatics, Imaging and Data Sciences, Faculty of Biology, Medicine and Health; and.
Magnus RattrayDivision of Informatics, Imaging and Data Sciences, Faculty of Biology, Medicine and Health; and.ORCID 0000-0001-8196-5565
Valerie KouskoffDivision of Developmental Biology & Medicine, The University of Manchester, Manchester, United Kingdom.ORCID 0000-0001-9801-4993
Georges LacaudStem Cell Biology Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, United Kingdom.ORCID 0000-0002-5630-2417
University of Manchester · GBUniversité Claude Bernard Lyon 1 · FRHospital del Mar Research Institute · ES

Funding

Biotechnology and Biological Sciences Research Council BB/R007209/1Cancer Research UK C5759/A20971Medical Research Council MR/P000673/1Medical Research Council MR/T000384/1
6 · The paper itself

Abstract

In vitro generation and expansion of hematopoietic stem cells (HSCs) holds great promise for the treatment of any ailment that relies on bone marrow or blood transplantation. To achieve this, it is essential to resolve the molecular and cellular pathways that govern HSC formation in the embryo. HSCs first emerge in the aorta-gonad-mesonephros (AGM) region, where a rare subset of endothelial cells, hemogenic endothelium (HE), undergoes an endothelial-to-hematopoietic transition (EHT). Here, we present full-length single-cell RNA sequencing (scRNA-seq) of the EHT process with a focus on HE and dorsal aorta niche cells. By using Runx1b and Gfi1/1b transgenic reporter mouse models to isolate HE, we uncovered that the pre-HE to HE continuum is specifically marked by angiotensin-I converting enzyme (ACE) expression. We established that HE cells begin to enter the cell cycle near the time of EHT initiation when their morphology still resembles endothelial cells. We further demonstrated that RUNX1 AGM niche cells consist of vascular smooth muscle cells and PDGFRa+ mesenchymal cells and can functionally support hematopoiesis. Overall, our study provides new insights into HE differentiation toward HSC and the role of AGM RUNX1+ niche cells in this process. Our expansive scRNA-seq datasets represents a powerful resource to investigate these processes further.

Indexed as

HematopoiesisAnimalsCell DifferentiationEmbryo, MammalianHemangioblastsHematopoietic Stem CellsMesonephrosMiceSingle-Cell AnalysisTranscriptomeZebrafish

Identifiers

PMID34517413
PMCPMC9159109
OpenAlexW3201343501

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.